Monte Carlo model of the Studsvik BNCT clinical beam: Description an validation

Medical Physics

Volumn 30, Issue 12, 2003, Pages 3107-3117

  Giusti, Valerio ^a   Munck Af Rosenschöld, Per M ^b   Sköld, Kurt ^c   Montagnini, Bruno ^a   Capala, Jacek ^d  

^a UNIVERSITY OF PISA   (Italy)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Studsvik Medical AB   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

BNCT; Epithermal neutron beam; Monte Carlo; Nuclear reactor

Indexed keywords

COMPUTATION THEORY; COMPUTATIONAL METHODS; NEUTRON BEAMS; NEUTRON FLUX; NUCLEAR REACTORS; PHANTOMS;

BNCT; BORON NEUTRON CAPTURE THERAPY; CALCULATION PROCEDURE; COMPUTATIONAL MODEL; EPITHERMAL NEUTRON; EPITHERMAL NEUTRON BEAMS; EXPERIMENTAL VALUES; THERMAL-NEUTRON FLUX;

MONTE CARLO METHODS;

ARTICLE; CALCULATION; MEASUREMENT; MONTE CARLO METHOD; NEUTRON CAPTURE THERAPY; PHANTOM; PRIORITY JOURNAL; SIMULATION; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

EID: 0346994903     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1626120     Document Type: Article

References (43)

1. G. L. Locher, "Biological effects and therapeutic possibilities of neutrons," Am. J. Roentgenol. Radium Ther. 36, 1-13 (1936).
2. R. F. Barth, A. H. Soloway, J. H. Goodman, R. A. Gahbauer, N. Gupta, T. E. Blue, W. Yang, and W. Tjarks, "Boron neutron capture therapy of brain tumors: An emerging therapeutic modality," Neurosurgery 3, 433-451 (1999).
3. R. G. Fairchild and V. P. Bond, "Current status of 10-B neutron capture therapy: Enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: A theoretical evaluation," Int. J. Radiat. Oncol., Biol., Phys. 11, 831-840 (1985).
4. E. Bisceglie, P. Colangelo, N. Colonna, P. Santorelli, and V. Variale, "On the optimal energy of epithermal neutron beams for BNCT," Phys. Med. Biol. 45, 49-58 (2000).
5. TM-A general Monte Carlo N-particle transport code. Version 4B," LA-12625-M, Los Alamos National laboratory, 1997.
6. DOORS3.2: One-, two-, and three-dimensional discrete ordinates neutron/photon transport code system, RSICC CODE PACKAGE CCC-650, 1998.
7. A. X. Ahnesjo and M. M. Aspradakis, "Dose calculations for external photon beams in radiotherapy," Phys. Med. Biol. 44, R99-155 (1999).
8. H. X. Auterinen et al., "Metamorphosis of a 35 years-old TRIGA reactor into a modern BNCT facility," in Frontiers in Neutron Capture Therapy, Vol. I, edited by M. F. Hawthorne et al. (Kluwer Academic, New York, 2001), pp. 267-275.
9. R. G. Fairchild, J. Kalef-Ezra, S. K. Saraf, S. Fiarman, E. Ramsay, L. Wielopolski, B. H. Laster, and F. Wheeler, "Installation and testing of an optimized epithermal neutron beam at the Brookhaven Medical Research Reactor," in Neutron Beam Design, Development, and Performance for Neutron Capture Therapy, edited by O. Harling and R. Zamenhof (Plenum, New York, 1990), pp. 158-199.
10. W. S. Kiger III, S. Sakamoto, and O. K. Harling, "Neutronic design of a fission converter-based neutron beam for neutron capture therapy," Nucl. Sci. Eng. 131, 1-22 (1999).
11. M. Maučec, "Feasibility of the utilization of BNCT in thermalizing column of TRIGA reactor," in Ref. 8, pp. 337-343.
12. T. Kobayashi, Y. Sakurai, K. Kanda, Y. Fujita, and K. Ono, "The remodeling and basic characteristics of the Heavy Water Neutron Irradiation Facility at Kyoto University Research Reactor mainly for neutron capture therapy," Nucl. Technol. 131, 354-378 (2000).
13. B. Montagnini, N. Cerullo, V. Giusti, and M. Sumini, "Feasibility of a small accelerator driven subcritical reactor for BNCT applications," Proceedings of the 9th International Conference of Radiation Shielding, J. of Nuclear Science and Technology, 2000, pp. 389-393.
14. O. K. Harling, G. Khose, K. J. Riley, and S. Sakamoto, "The use of polytetrafluoroethylene (TEFLON®) containing filter/moderators for epithermal neutron beam production," in Ref. 8, pp. 363-367.
15. G. Constantine, "The physics and technology of NCT: An overview," in Advances in Neutron Capture Therapy, edited by B. Larsson et al. (Elsevier Science, Amsterdam, 1997). pp. 301-310.
16. Y. Sakurai and T. Kobayashi, "Controllability of depth dose distribution for neutron capture therapy at the Heavy Water Neutron Irradiation Facility of Kyoto University Research Reactor," Med. Phys. 29, 2338-2350 (2002).
17. P. M. Busse, R. Zamenhof, H. Madoc-Jones, G. Solares, S. Kiger, K. Riley, C. Chuang, G. Rogers, and O. Harling, "Clinical follow-up of patients with melanoma of the extremity treated in a phase I boron neutron capture therapy," in Ref. 15, pp. 60-64.
18. J. X. Hiratsuka, H. Fukada, T. Kobayashi, K. Kanda, C. Honda, M. Ichihashi, and M. Mishima, "Human melanoma treated by boron neutron capture therapy: Comparison of the clinical response with the predicted response," Radiat. Med. 14, 257-263 (1996).
19. 10B-L-borophenylalanine for boron neutron capture therapy," Br. J. Radiol. 71, 320-323 (1998).
20. J. T. Goorley, W. S. Kiger III, and R. G. Zamenhof, "Reference dosimetry calculations for neutron capture therapy with comparison of analytical and voxel models," Med. Phys. 29, 145-156 (2002).
21. J. A. Umbarger et al., "SIMULATE-3-Advanced Three-Dimensional Two-Group Reactor Analysis Code," Studsvik/SOA-92/01.
22. V. Giusti, "Neutronic design and validation of a facility for boron neutron capture therapy and research," Ph.D. thesis, University of Pisa, 2003.
23. NEA Nuclear Science Committee, "International handbook of evaluated criticality safety benchmark experiments," NEA/NSC/DOC(95), September, 1999, Edition.
24. R. S. Caswell, J. J. Coyne, and M. L. Randolph, "Kerma factors of elements and compounds for neutron energies below 30 MeV," Int. J. Appl. Radiat. Isot. 33, 1227-1262 (1982).
25. ICRP Publication 23, Reference Man: Anatomical, Physiological and Metabolic Characteristics (Pergamon, Oxford, 1975).
26. Y. D. Harker, R. A. Anderl, G. K. Becker, and L. G. Miller, "Spectral characterization of the epithermal neutron beam at the Brookhaven Medical Research reactor," Nucl. Sci. Eng. 110, 355-368 (1992).
27. D. W. Nigg, J. K. Hartwell, Y. D. Harker, C. A. Wemple, J. Capala, K. Sköld, and J. Kierkeegard, "Collaborative neutronic performance characterization of the Studsvik AB clinical epithermal-neutron beam facility for BNCT," INEEL/EXT-01-00520, April 2001.
28. P. M. Munck af Rosenschöld, V. Giusti, C. P. Ceberg, J. Capala, K. Sköld, and B. R. R. Persson, "Reference dosimetry at the boron neutron capture therapy facility at Studsvik," Med. Phys. 30, 1569-1579 (2003).
29. O. K. Harling et al., "The fission converter-based epithermal neutron irradiation facility at the Massachusetts Institute of Technology, " Nucl. Sci. Eng. 140, 223-240 (2002).
30. G. Gambarini, C. Colombi, B. Lietti, S. Agosteo, K. W. Burn, E. Nava, R. Tinti, O. Fiorani, A. Perrone, and G. Rosi, "Measurements and calculations of neutron flux and dose rates for an experimental epithermal facility at the TAPIRO fast reactor," in Research and Development in Neutron Capture Therapy, edited by W. Sauerwein et al. (Monduzzi Editore, Bologna, 2002), pp. 367-371.
31. J. Zoetelief, D. Schlegel-Bickmann, H. Schraube, and G. Dietze, "Characteristics of Mg/Ar ionisation chambers used as gamma-ray dosemeters in mixed neutron-photon fields," Phys. Med. Biol. 31, 1339-1351 (1986).
32. P. M. Munck af Rosenschöld, C. P. Ceberg, V. Giusti, and P. Andreo, "Photon correction quality factors for ionization chambers in an epithermal neutron beam," Phys. Med. Biol. 47, 2397-2409 (2002).
33. R. B. Firestone, V. S. Shirley, C. M. Baglin, S. Y. F. Chu, and J. Zipkin, Table of Isotopes, 8th ed. (Wiley, New York, 1996).
34. J. H. Hubbell, "Photon mass attenuation and energy-absorption coefficients from 1 keV to 20 MeV," Int. J. Appl. Radiat. Isot. 33, 1269-1290 (1982).
35. IAEA, Current Status of Neutron Capture Therapy, Vienna, 2001, IAEA-TECDOC-1223, ISSN 1011-4289.
36. H. Beckurts and K. Wirtz, Neutron Physics (Springer-Verlag, Berlin, 1964).
37. C. P. J. Raaijmakers, M. W. Konijnenberg, H. W. Verhagen, and B. J. Mijnheer, "Determination of dose components in an epithermal neutron beam for boron neutron capture therapy," Med. Phys. 22, 321-329 (1995).
38. S. Sakamoto, W. S. Kiger III, and O. K. Harling, "Sensitivity studies of beam directionality, beam size, and neutron spectrum for a fission converter-based epithermal neutron beam for boron neutron capture therapy, " Med. Phys. 26, 1979-1998 (1999).
39. R. G. Zamenhof, B. W. Murray, G. L. Brownell, G. R. Wellum, and E. I. Tolpin, "Boron neutron capture therapy for the treatment of cerebral gliomas: I. Theoretical evaluation of the efficacy of various neutron beams," Med. Phys. 2, 47-60 (1975).
40. J. Capala et al., "Boron neutron capture therapy for glioblastoma multiforme: Clinical studies in Sweden," J. Neuro-Oncol. 62, 135-144 (2003).
41. J. A. Coderre, A. D. Chanana, D. D. Joel, E. H. Elowitz, P. L. Micca, M. M. Nawrocky, M. Chadha, J. O. Gebbers, M. Shady, N. S. Peress, and D. N. Slatkin, "Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity," Radiat. Res. 149, 163-170 (1998).
42. J. A. Coderre and G. R. Morris, "The radiation biology of boron neutron capture therapy," Radiat. Res. 151, 1-18 (1999).
43. S.-J. Ye, "Boron self-shielding effects on dose delivery of neutron capture therapy using epithermal beam and boronophenylalanine," Med. Phys. 26, 2488-2493 (1999).